Skip to main content
. 2019 Aug 12;9(20):5828–5838. doi: 10.7150/thno.34837

Figure 8.

Figure 8

In vivo tumor image and antitumor effect of the Dox-HepM-PLGA. (A) Fluorescence image of HepG2 tumor-bearing nude mice 3 days,7 days and 11 days after the intravenous injection of Dox-HepM-PLGA. (B) Photos of ex vitro the tumors extracted from the nude mice bearing the HepG2 tumor 3 days, 7 days and 11 days after the intravenous injection of Dox-HepM-PLGA. (C) Ex vitro fluorescence images of the major organs and tumors tissues extracted from the nude mice bearing the HepG2 tumor 3 days, 7 days and 11 days after the intravenous injection of Dox-HepM-PLGA and its counterparts. (D) Hematoxylin and Eosin (H&E) staining of the tissue slices of HepG2 tumor-bearing nude mice 3 days,7 days and 11 days after the intravenous injection of Dox-HepM-PLGA. Scale bar: 50 μm.